NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational Update

NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies for central nervous system (CNS) cancers, today ...

SouthGobi Announces Third Quarter 2025 Unaudited Financial and Operating Results

HONG KONG, CHINA / ACCESS Newswire / November 14, 2025 / SouthGobi Resources Ltd. (Hong Kong Stock Exchange ("HKEX"):1878, TSX Venture Exchange ("TSX-V"):SGQ) (the "Company" or "SouthGobi") today ...